The reason remains unclear: U.S. opioid overdose deaths fell after May 2023, but more overdose rescues may not explain the drop. Naloxone is a medicine that can quickly reverse an opioid overdose. Wider access has received much of the credit for falling deaths. A University of Pittsburgh team helped examine that explanation using national emergency response records. Those records covered May 2020 through December 2025. The study appeared in JAMA on October 21. The article reports that deaths peaked after more than 30 years of increases. Researchers asked whether more rescue doses drove the decline that followed. They described a pattern they would expect if that were true: overdoses that people survived would keep rising, alongside more medicine use per overdose. The provided article does not give the study’s exact results or percentages. It instead points to fewer overdoses as a key issue needing explanation. Possible reasons include changes in the strength of fentanyl, a powerful opioid. Changes in drug use and community behavior could also matter. These are ideas being explored, not proven causes. The team plans to examine shifts from injecting drugs to smoking them. They want to see whether those shifts match faster drops in deaths. For BioSocial members, saving someone during an overdose and explaining national trends are different questions. Tracking access and carrying habits can still support useful community conversations. Personal notes might include days carried or barriers to getting a supply. Comparing those experiences can reveal local gaps, without claiming to explain national death rates. What has changed in your access or carrying habits over time?